AnteoTech Ltd
ADO
Company Profile
Business description
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.
Contact
4/26 Brandl Street
Eight Mile Plains
BrisbaneQLD4113
AUST: +61 732190085
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
40
Stocks News & Analysis
stocks
Moated ASX player’s future growth prospects look solid
We expect the strong earnings momentum at this company to continue, with shares looking fairly valued.
stocks
Ask the analyst: Can this genius product create the next ASX software king?
SiteMinder’s newly released product for hotel owners and travel agents could widen its moat and see revenue accelerate further.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,039.80 | 82.70 | -0.91% |
| CAC 40 | 7,869.69 | 51.47 | 0.66% |
| DAX 40 | 23,655.09 | 295.91 | 1.27% |
| Dow JONES (US) | 46,242.99 | 224.67 | 0.49% |
| FTSE 100 | 9,241.88 | 46.22 | 0.50% |
| HKSE | 26,663.80 | 225.29 | 0.85% |
| NASDAQ | 22,506.31 | 244.98 | 1.10% |
| Nikkei 225 | 45,321.95 | 419.68 | 0.93% |
| NZX 50 Index | 13,120.03 | 114.86 | -0.87% |
| S&P 500 | 6,649.60 | 49.25 | 0.75% |
| S&P/ASX 200 | 8,754.80 | 93.70 | -1.06% |
| SSE Composite Index | 3,864.81 | 11.53 | -0.30% |